• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2024年全球关于消除乙型肝炎的国家政策、计划及进展报告:33份消除肝炎概况的调查结果》

A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles.

作者信息

Hiebert-Suwondo Lindsey, Manning Jana, Tohme Rania A, Buti Maria, Kondili Loreta A, Spearman C Wendy, Prabdial-Sing Nishi, Turnier Victoria, Lazarus Jeffrey V, Waked Imam, Ward John W

机构信息

Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.

Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.

出版信息

Lancet Gastroenterol Hepatol. 2025 Jul;10(7):671-684. doi: 10.1016/S2468-1253(25)00069-X. Epub 2025 May 20.

DOI:10.1016/S2468-1253(25)00069-X
PMID:40409324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12308976/
Abstract

The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, policy, and programme development the elimination of viral hepatitis. Profiles from 33 countries and territories show progress, towards elimination of hepatitis B with 24 (73%) of them meeting the 2025 WHO interim target of 0·5% or less HBsAg prevalence in children younger than 5 years. 22 (67%) of countries and territories profiled have policies for universal hepatitis B birth-dose vaccination of newborns. Access to hepatitis B testing and treatment, including removing HBsAg screening and hepatitis B treatment patient co-payments and simplifying treatment algorithms, remains suboptimal, especially in low-income and middle-income countries and territories. Of the seven profiled countries and territories meeting the 60% WHO 2025 diagnosis coverage target, all but one (Rwanda) is a high-income country or territory. No country or territory has met the WHO 2025 treatment target of at least 50% of people living with hepatitis B receiving treatment. The profiles guide national planning and identify priorities for resource mobilisation to further accelerate hepatitis B elimination.

摘要

全球消除肝炎联盟的《国家肝炎消除概况》评估了各国在病毒性肝炎消除方面的数据、政策和项目发展状况。来自33个国家和地区的概况显示,在消除乙型肝炎方面取得了进展,其中24个国家(73%)实现了世界卫生组织2025年的中期目标,即5岁以下儿童的乙肝表面抗原(HBsAg)流行率降至0.5%或更低。在纳入概况的国家和地区中,22个(67%)制定了针对新生儿普遍接种首剂乙肝疫苗的政策。获得乙肝检测和治疗的情况,包括取消HBsAg筛查和乙肝治疗患者自付费用以及简化治疗方案,仍不尽人意,尤其是在低收入和中等收入国家及地区。在纳入概况的七个实现了世界卫生组织2025年60%诊断覆盖率目标的国家和地区中,除一个国家(卢旺达)外,其余均为高收入国家或地区。没有国家或地区实现世界卫生组织2025年的治疗目标,即至少50%的乙肝感染者接受治疗。这些概况为国家规划提供指导,并确定资源调动的优先事项,以进一步加速消除乙型肝炎。

相似文献

1
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles.《2024年全球关于消除乙型肝炎的国家政策、计划及进展报告:33份消除肝炎概况的调查结果》
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):671-684. doi: 10.1016/S2468-1253(25)00069-X. Epub 2025 May 20.
2
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles.一份关于丙型肝炎消除的国家政策、计划及进展的2024年全球报告:来自33份肝炎消除概况的调查结果
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):685-700. doi: 10.1016/S2468-1253(25)00068-8. Epub 2025 May 20.
3
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.1980年至2023年全球、区域和国家儿童常规疫苗接种覆盖率趋势及2030年预测:2023年全球疾病负担研究的系统分析
Lancet. 2025 Jun 24. doi: 10.1016/S0140-6736(25)01037-2.
4
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
5
Born Too Soon: learning from the past to accelerate action in the next decade.过早出生:从过去吸取教训,加速未来十年的行动。
Reprod Health. 2025 Jun 23;22(Suppl 2):106. doi: 10.1186/s12978-025-02044-8.
6
Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.孕期使用乙型肝炎免疫球蛋白预防乙肝病毒母婴传播。
Cochrane Database Syst Rev. 2017 Feb 11;2(2):CD008545. doi: 10.1002/14651858.CD008545.pub2.
7
Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis.世界卫生组织非洲区域乙型肝炎病毒的垂直传播:一项系统评价和荟萃分析
Lancet Glob Health. 2025 Mar;13(3):e447-e458. doi: 10.1016/S2214-109X(24)00506-0.
8
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies.2014 - 2023年丙型肝炎病毒感染治疗人数及对新的乙肝和丁肝治疗方法的适用经验教训。
J Hepatol. 2025 Aug;83(2):329-347. doi: 10.1016/j.jhep.2025.01.013. Epub 2025 Feb 4.
9
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
10
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.急性乙型肝炎感染的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD011645. doi: 10.1002/14651858.CD011645.pub2.

引用本文的文献

1
World Hepatitis Day 2025: Progress and Challenges in the Global Elimination of Viral Hepatitis.2025年世界肝炎日:全球消除病毒性肝炎的进展与挑战
China CDC Wkly. 2025 Jul 25;7(30):987-990. doi: 10.46234/ccdcw2025.167.
2
Viral hepatitis: breaking down barriers.病毒性肝炎:打破障碍。
Nat Rev Gastroenterol Hepatol. 2025 Sep;22(9):597. doi: 10.1038/s41575-025-01101-8.

本文引用的文献

1
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles.一份关于丙型肝炎消除的国家政策、计划及进展的2024年全球报告:来自33份肝炎消除概况的调查结果
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):685-700. doi: 10.1016/S2468-1253(25)00068-8. Epub 2025 May 20.
2
New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020.中国乙肝控制新进展及乙肝感染者医疗保健级联服务:来自2020年第四次全国血清学调查的证据
Lancet Reg Health West Pac. 2024 Sep 14;51:101193. doi: 10.1016/j.lanwpc.2024.101193. eCollection 2024 Oct.
3
Time for a treat all approach for hepatitis B.是时候采取全面治疗乙肝的方法了。
Lancet Gastroenterol Hepatol. 2024 Aug;9(8):688-689. doi: 10.1016/S2468-1253(24)00192-4.
4
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.消除病毒性肝炎的进展:《柳叶刀·胃肠病学和肝病学》委员会最新报告
Lancet Gastroenterol Hepatol. 2024 Apr;9(4):346-365. doi: 10.1016/S2468-1253(23)00321-7. Epub 2024 Feb 15.
5
A global investment case for hepatitis B elimination: a modelling study.全球消除乙型肝炎投资案例:建模研究。
Lancet Gastroenterol Hepatol. 2023 Oct;8(10):932-942. doi: 10.1016/S2468-1253(23)00156-5. Epub 2023 Jul 27.
6
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study.韩国消除乙型和丙型肝炎病毒感染的核心指标:一项全国性研究。
Clin Mol Hepatol. 2023 Jul;29(3):779-793. doi: 10.3350/cmh.2023.0110. Epub 2023 May 15.
7
Prevalence and awareness of Hepatitis B virus infection in the United States: January 2017 - March 2020.美国乙型肝炎病毒感染的流行率和知晓率:2017 年 1 月至 2020 年 3 月。
Hepatol Commun. 2023 Mar 30;7(4). doi: 10.1097/HC9.0000000000000118. eCollection 2023 Apr 1.
8
The impact of the timely birth dose vaccine on the global elimination of hepatitis B.及时出生剂量疫苗对全球消除乙型肝炎的影响。
Nat Commun. 2021 Oct 28;12(1):6223. doi: 10.1038/s41467-021-26475-6.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey.格鲁吉亚乙型肝炎和丁型肝炎的负担和流行病学:全国血清流行率调查结果。
Public Health. 2020 Aug;185:341-347. doi: 10.1016/j.puhe.2020.06.024. Epub 2020 Jul 29.